GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

ontunisertib   Click here for help

GtoPdb Ligand ID: 13846

Synonyms: AGMB-129 | Example 26 [WO2021105317A1] | ORG-129
Compound class: Synthetic organic
Comment: The chemical structure for ontunisertib was obtained from WHO INN proposed list 132. This matched a structure claimed in patent WO2021105317A1 (Origo Biopharma) [1]. This patent claims the compound as a transforming growth factor β receptor 1 (TGFβR1)/ALK5 inhibitor. This is likely one of Origo's lead assets ORG-129 (a gastrointestinal tract restricted inhibitor for fibrostenotic Crohn's disease) or ORG-447 (a lung-restricted inhibitor for idiopathic pulmonary fibrosis), most probably ORG-129 as this has progressed to clinical trial.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 69.42
Molecular weight 469.49
XLogP 1.35
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CC=CC(=N1)C2=NN(C=C2C3=C4C=CC=CC4=NC=C3)CC(=O)NCC5=C(C=CC=C5F)F
Isomeric SMILES FC1=C(C(=CC=C1)F)CNC(CN2N=C(C(=C2)C3=CC=NC4=CC=CC=C34)C5=NC(=CC=C5)C)=O
InChI InChI=1S/C27H21F2N5O/c1-17-6-4-11-25(32-17)27-21(18-12-13-30-24-10-3-2-7-19(18)24)15-34(33-27)16-26(35)31-14-20-22(28)8-5-9-23(20)29/h2-13,15H,14,16H2,1H3,(H,31,35)
InChI Key QGXRIRYULXOGDQ-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
transforming growth factor beta receptor 1 Hs Inhibitor Inhibition >6.3 – 7.0 pIC50 - 1
pIC50 >7.0 (IC50 <1x10-7 M) [1]
Description: Determined in a biochemical ADP-Glo kinase inhibition assay
pIC50 6.3 – 7.0 (IC50 5x10-7 – 1x10-7 M) [1]
Description: Determined in a cellular assay using TGF-stimulated A549 cells